Back to search

Article

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers

2025-03-04

Abstract excerpt

Metastatic prostate cancer (mPCa) remains a significant global health concern and cause of cancer-related mortality in men. Advances in molecular profiling have illuminated the critical drivers of disease progression and therapeutic resistance, notably within the androgen receptor (AR) axis, DNA damage repair (DDR) pathways, and PI3K/AKT/mTOR network. Despite the established benefits of hormone therapy, chemothera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76dcde1d-6daf-513a-a0b3-f66f78270f8a
DOI
10.20944/preprints202503.0213.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic FrontiersDOI 10.20944/preprints202503.0213.v1
Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized TherapySemantic proximity
Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic.Semantic proximity
Future directions for precision oncology in prostate cancerSemantic proximity
Emerging Biomarker-Guided Therapies in Prostate CancerSemantic proximity
Precision medicine for advanced prostate cancer.Semantic proximity
De Novo Metastatic Prostate Cancer: Are We Moving towards a Personalized Treatment?Semantic proximity
De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?Semantic proximity
Molecular landscape of prostate cancer: Implications for current clinical trialsSemantic proximity
Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate CancerSemantic proximity
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKTSemantic proximity
Clinical implications of genomic alterations in metastatic prostate cancer.Semantic proximity
Association between DNA damage repair alterations and outcomes to 177Lu-PSMA-617 in advanced prostate cancerSemantic proximity
Select a neighboring publication to make it the new centre.